These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6612073)

  • 1. [Hyperinsulinism and insulin resistance diagnosed by oral and intravenous glucose loading and by the tolbutamide test in polycystic ovary syndrome].
    Cotrozzi G; Matteini M; Relli P; Lazzari T
    Recenti Prog Med; 1983 Mar; 74(3):289-97. PubMed ID: 6612073
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperinsulinism and insulin resistance in polycystic ovarian syndrome: a verification using oral glucose, I.V. Glucose and tolbutamide.
    Cotrozzi G; Matteini M; Relli P; Lazzari T
    Acta Diabetol Lat; 1983; 20(2):135-42. PubMed ID: 6224386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperinsulinism and insulin resistance in the polycystic ovary syndrome as tested with tolbutamide].
    Matteini M; Cotrozzi G; Bufalini GN; Relli P; Lazzari T
    Boll Soc Ital Biol Sper; 1982 Nov; 58(22):1455-60. PubMed ID: 6762218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenous glucose tolerance test in the polycystic ovary syndrome].
    Relli P; Cotrozzi G; Matteini M; Lazzari T; Bufalini GN
    Boll Soc Ital Biol Sper; 1982 Nov; 58(22):1451-4. PubMed ID: 6762217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral glucose tolerance test in polycystic ovary syndrome].
    Cotrozzi G; Matteini M; Relli P; Lazzari T; Bufalini GN
    Boll Soc Ital Biol Sper; 1982 Nov; 58(22):1446-50. PubMed ID: 6762216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinemia in polycystic ovary disease.
    Arthur LS; Selvakumar R; Seshadri MS; Seshadri L
    J Reprod Med; 1999 Sep; 44(9):783-7. PubMed ID: 10509302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and diabetes.
    Bompiani GD; Laudicina E
    Isr J Med Sci; 1972 Jun; 8(6):823-6. PubMed ID: 5051806
    [No Abstract]   [Full Text] [Related]  

  • 8. Odd variation of 75 g oral glucose tolerance test results in a Japanese patient with polycystic ovary syndrome: a case report.
    Takahashi K; Mutiara S; Kita N; Tsuji S; Noda Y; Miyazaki K
    Arch Gynecol Obstet; 2007 May; 275(5):405-9. PubMed ID: 17103180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.
    Legro RS; Castracane VD; Kauffman RP
    Obstet Gynecol Surv; 2004 Feb; 59(2):141-54. PubMed ID: 14752302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.
    Luque-Ramírez M; Alvarez-Blasco F; Botella-Carretero JI; Sanchón R; San Millán JL; Escobar-Morreale HF
    Diabetes Care; 2007 Sep; 30(9):2309-13. PubMed ID: 17536071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
    Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metformin for the treatment of polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M
    Akush Ginekol (Sofiia); 2005; 44(4):37-41. PubMed ID: 16028378
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S69-73. PubMed ID: 19007650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease.
    Fulghesu AM; Lanzone A; Cucinelli F; Caruso A; Mancuso S
    Obstet Gynecol; 1993 Aug; 82(2):191-7. PubMed ID: 8336863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of HOMA IR with the minimal model for measuring insulin sensitivity in polycystic ovary syndrome].
    Amador N; Espinoza G; Guízar JM; González M; Alpízar M
    Rev Invest Clin; 2001; 53(5):407-12. PubMed ID: 11795106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease in adiponectin levels in women with polycystic ovary syndrome after an oral glucose tolerance test.
    Panidis D; Farmakiotis D; Rousso D; Koliakos G; Kaltsas T; Krassas G
    Fertil Steril; 2005 Jan; 83(1):232-4. PubMed ID: 15652919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome.
    Legro RS
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1367-78. PubMed ID: 12510993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS.
    Sawathiparnich P; Weerakulwattana L; Santiprabhob J; Likitmaskul S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S33-7. PubMed ID: 16856423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.